Our latest set of GCBR Organization Updates is our longest issue yet, featuring statements on AIxBio risks, RFPs for clean indoor air, hiring for biosurveillance, resilient synthesis screening, and more!
US health agencies like CDC and NIH and FDA remain full of dedicated and exceptional scientists and health professionals doing the right thing for public health. But this example shows they can be overruled by an exceptionally unqualified secretary of HHS.
I'm fortunate to live in a state with a high-quality health department that provides information based on science. For those who don't I recommend Canadian https://t.co/rUStXWqqKV or UK https://t.co/dA3IO4XrPD advice.
@_akiraendo I’ve had that experience with Cell and with Scientific Reports. Maybe a good reason to avoid donating your labor to that journal! And tell them
Why
We will kick off the @ColumbiaMSPH seminar series on infectious disease modeling in the spring semester with a fantastic talk by Dr. Marc Lipsitch @mlipsitch from @CCDD_HSPH@HarvardChanSPH! Welcome to join in person or over Zoom on 1/21.
Register here: https://t.co/a8v0X8W3AW
Excited to share a new preprint led by Indra Gonzalez Ojeda on a new tool to improve pangenome calling in bacteria, CLARC. https://t.co/BAnSAaFf26 . Passing output of Roary for S. pneumoniae populations through this tool reduces accessory genome > 30%, resolves other puzzles
My profound thought for today: Jargon and buzzwords are opposites. Jargon are words almost no one uses that have precise meaning. Buzzwords are words everyone uses that have little meaning. Clarity is avoiding both.
Trump’s Project 2025 explained hilariously, terrifyingly, and perfectly.
Trump’s Project 2025 will end America as we know it and turn it into the White Christian Nationalist version of Afghanistan.
https://t.co/ylHBIjZW1H
Just out w @chrisbboyer https://t.co/uforF1tNsQ Emulating target trials of postexposure vaccines using observational data. Spurred by great collab with @nycHealthy on mpox vaccines, but applies to any postexposure intervention on an infection to reduce risk of bad outcomes.
Just out w @chrisbboyer https://t.co/cENkStkCUH Emulating target trials of postexposure vaccines using observational data. Spurred by great collab with @nycHealthy on mpox vaccines, but applies to any postexposure intervention on an infection to reduce risk of bad outcomes.